A phase II study of continuous intravenous infusion (CIVI) recombinant IL-2 and subcutaneous α-interferon by sequential administration in advanced renal cell cancer
Titel:
A phase II study of continuous intravenous infusion (CIVI) recombinant IL-2 and subcutaneous α-interferon by sequential administration in advanced renal cell cancer
Auteur:
Besana, C Baiocchi, C Borri, A Brando, B Bucci, E Citterio, G Di Lucca, G Fortis, C Landonio, G Tresoldi, M Ghislandi, E Rugarli, C